Eupraxia Pharmaceuticals (EPRX)

• Market cap: $414M
• 1 day: -6.58%
• 5 days: -3.66%
• 1 month: -16.47%
• 3 months: 1.43%
• 6 months: 6.77%
• Year to date: -6.21%
• 1 year: 81.59%
• 5 years: 140.68%
• 10 years: 140.68%
• Sector: Healthcare
• Industry: Biotechnology

About: Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.

Employees: 49